Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Tuesday:
Eli Lilly and Co., up $43.90 to $781.10.
The drugmaker raised its profit forecast for the year.
3M Co., up $4.35 to $96.51.
The maker of Post-it notes, industrial coatings and ceramics reported strong first-quarter financial results.
MicroStrategy Inc., down $227.94 to $1,065.03.
The business software company’s first-quarter financial results fell short of analysts’ forecasts.
Woodward Inc., up $11.29 to $162.36.
The maker of cockpit controls and other equipment for the defense and aerospace markets raised its financial forecast for the year.
Amkor Technology Inc., up 88 cents to $32.35.
The chip packaging and test services provider gave Wall Street an encouraging earnings forecast.
Trane Technologies Plc., up $16.48 to $317.34.
The maker of heating, ventilation and air conditioning equipment raised its profit forecast for the year.
Chegg Inc., down $2 to $5.17.
The online learning platform gave investors a weak revenue forecast for the year.
Tenet Healthcare Corp., UP $13.14 to $112.29.
The hospital operator raised its profit forecast for the year.
Related articles
- Lady Tatiana Mountbatten has revealed that she's so 'dedicated' to her fitness tracking watch that s2024-05-22
No casualties reported in Russian city of Orsk after dam breach
No injuries or fatalities were reported in the wake of a dam breach in the city of Orsk, Russia'2024-05-22Western 'overcapacity' accusation is typical double standard: China's commerce ministry
This photo taken on Oct. 4, 2022 shows wind turbines provided by China's Goldwind in Chaiyaphum,2024-05-22Nepal general advocates enhanced China
General Rajendra Chhetri, former Chief of Army Staff of Nepal, gives an interview with China.org.cn.2024-05-22Brazilian coach Sylvinho sworn in as Albanian citizen ahead of Euro 2024
TIRANA, Albania (AP) — Albania coach Sylvinho, a Brazilian, and his assistants were sworn in as Alba2024-05-22Experts challenge 'capacity' claims
Amid the ongoing rhetoric about China's so-called "overcapacity", there is a lack of s2024-05-22
atest comment